Shares of Hyperfine, Inc. (NASDAQ:HYPR – Get Free Report) have been assigned an average recommendation of “Hold” from the five ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $2.03.
Several brokerages have recently weighed in on HYPR. BTIG Research restated a “buy” rating and set a $2.00 target price on shares of Hyperfine in a research note on Tuesday, September 22nd. B. Riley Financial reiterated a “buy” rating and issued a $1.60 price target (down from $2.00) on shares of Hyperfine in a research note on Monday, August 10th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperfine in a report on Friday, July 17th.
View Our Latest Research Report on Hyperfine
Hyperfine Price Performance
Hyperfine (NASDAQ:HYPR – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.09). Hyperfine had a negative net margin of 210.75% and a negative return on equity of 97.88%. The firm had revenue of $3.90 million for the quarter, compared to the consensus estimate of $4.13 million. Equities research analysts anticipate that Hyperfine will post -0.34 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Hyperfine
Institutional investors have recently made changes to their positions in the business. Catalio Capital Management LP grew its position in shares of Hyperfine by 92.8% during the fourth quarter. Catalio Capital Management LP now owns 1,320,041 shares of the company’s stock worth $1,293,000 after buying an additional 635,500 shares in the last quarter. Renaissance Technologies LLC raised its holdings in Hyperfine by 100.2% in the first quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock valued at $789,000 after acquiring an additional 365,490 shares in the last quarter. Bank of New York Mellon Corp bought a new position in Hyperfine during the 2nd quarter valued at $419,000. Finally, Walleye Capital LLC boosted its stake in Hyperfine by 3.4% during the 1st quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock valued at $242,000 after acquiring an additional 7,330 shares during the last quarter. 15.03% of the stock is owned by institutional investors and hedge funds.
About Hyperfine
Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging (MRI) more accessible and convenient. Its flagship product, the Swoop Portable MR Imaging System, is designed to provide brain imaging at or near the patient’s bedside rather than requiring transport to a traditional MRI suite.
The Swoop system uses a low-field magnetic resonance platform, artificial intelligence-enabled image processing and a mobile design to support neuroimaging in settings such as hospitals, intensive care units and other clinical environments.
Featured Stories
- Five stocks we like better than Hyperfine
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.
